Design your branded product microsite header
Overview
Description:
Date/Time: September 28, 2023 | 12:00 - 12:15 pm ET
Sepsis is challenging, as presentations are heterogeneous and highly variable. Healthcare professionals are often tasked with making decisions for patients suspected of infection with incomplete evidence and insufficient tools. With sepsis, the most urgent question is whether the patient is having a dysregulated immune response to the infection. This is where the novel, FDA-cleared IntelliSep test comes in. IntelliSep interrogates white blood cells by utilizing host response technology to assess their activation state and provides a window into the patient’s potential for immune dysregulation - the crux of sepsis - in under 10 minutes. In this sponsored presentation, learn from providers who have utilized IntelliSep in clinical practice about how the test has supported their goal to optimize the early identification of sepsis, and helped them get the right care, to the right patient, at the right time.
Sponsored by Cytovale
Speaker(s)
Hollis (Bud) O'Neal, MD
Associate Professor of Medicine
Louisiana State University Health Sciences Center
Bud O’Neal, MD, is an Associate Professor of Clinical Medicine at LSU Health Sciences Center (LSUHSC) and the Medical Director of Research for Our Lady of the Lake Regional Medical Center in Baton Rouge. Dr. O’Neal graduated from Vanderbilt University with a Bachelor of Science in Molecular Biology and Computer Science, and subsequently completed medical school at the Louisiana State University Health Sciences Center in New Orleans. He completed his internal medicine residency at the Louisiana State University Health Sciences Center in Baton Rouge. He then completed Pulmonary and Critical Care Medicine training at Vanderbilt University, where he also earned a Master of Science in Clinical Investigation. Dr. O’Neal is a member of the American Thoracic Society, American Society of Microbiology, and the American Academy for the Advancement of Science. He is an active investigator in clinical trials, including industry-sponsored, NIH-funded, and investigator-initiated studies. His research interests include sepsis diagnosis and treatment.
Summit 2024 Session: Cytovale Sponsored Session: IntelliSep Revolutionizes Early Sepsis Detection: Real Cases and a Patient Story
Session Day/Time: Thursday, September 26, 2024, 1:45 PM - 2:00 PM EST
Mark Laperouse, MD
Medical Director, Emergency Services
Our Lady of the Lake Regional Medical Center
Mark Laperouse, MD, is an emergency trained physician. He attended Tulane University as an undergraduate, where he earned a Bachelor of Science in Cell and Molecular Biology. He then had an unconventional medical school experience, starting at LSU New Orleans and finishing at the Medical University of South Carolina in Charleston because of Hurricane Katrina. His residency training took place in Jacksonville, Florida at Shands Hospital. Dr. Laperouse continues to practice at Our Lady of the Lake in the emergency department where he is the Medical Director. He also serves as the Chief Medical Officer for the Louisiana market of Emergency Care Partners. He was born in New Orleans and raised in Mandeville, and he currently resides in Baton Rouge with his wife and four boys.
Summit 2024 Session: Cytovale Sponsored Session: IntelliSep Revolutionizes Early Sepsis Detection: Real Cases and a Patient Story
Session Day/Time: Thursday, September 26, 2024, 1:45 PM - 2:00 PM EST
Course Contents
Register for Conference
Click here to register for Sepsis Alliance Summit.